LABD: ETF To Benefit From Downturns In The Biotech Industry
Source: SeekingAlpha
2026-01-26 09:19:21 ET
Fast Facts About the Direxion Daily S&P Biotech Bear 3x Shares ETF
Read the full article on Seeking Alpha
For further details see:
LABD: ETF To Benefit From Downturns In The Biotech Industry
Mirum Pharmaceuticals Inc.
NASDAQ: MIRM
MIRM Trading
1.51% G/L:
$91.61 Last:
117,631 Volume:
$90.76 Open:
MIRM Latest News
March 16, 2026 08:00:00 am
Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases
March 05, 2026 08:00:00 am
Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
MIRM Stock Data
$5,184,583,745
44,013,457
0.43%
119
N/A
Biotechnology & Life Sciences
Healthcare
US
Foster City
